Endovascular Today

Endovascular Today is a dedicated publication that focuses on providing in-depth insights into the newest technologies, techniques, and advancements in the endovascular sector. Our Editorial Advisory Board consists of leading experts in the field, including interventional cardiologists, interventional radiologists, vascular surgeons, neurointerventionists, and specialists in vascular medicine. Our readership includes over 22,000 professionals from the endovascular community. We publish Endovascular Today 12 times a year, and we also offer a complimentary biweekly eNewsletter that keeps you updated on the latest FDA approvals, clinical trial news, Medicare coverage changes, and new product introductions. For more information on how to subscribe to Endovascular Today, please visit our subscriptions page.

Trade/B2B, Consumer

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#488580

United States

#200419

Health/Medicine

#1550

Traffic sources

Monthly visitors

Articles

SAFE-IVC Study Finds Declining Use of IVC Filters But Need for Improved Rates of Timely Retrieval

Jan 17, 2025 | evtoday.com | Eric A. Secemsky

In a large, real-world analysis of United States Medicare fee-for-service patients, Ferro et al found that inferior vena cava filter (IVC) use declined over the study period, but the cumulative rate of retrieval was low, suggesting a need for strategies to achieve timely retrieval. The results were published in JAMA.1 The SAFE-IVC study was designed in collaboration with the FDA in an effort to better understand contemporary IVC filter use and outcomes.
Multidisciplinary Aortic Dissection Teams

Nov 20, 2024 | evtoday.com | Rana Afifi |Michael J. Troncone

The concept of having dedicated teams for specific cardiovascular diseases is not new.
Patient-Centered Aortic Dissection Care

Nov 20, 2024 | evtoday.com | Rana Afifi

When I was invited by Endovascular Today to serve as Guest Chief Medical Editor of an edition on aortic dissection (AD), I considered the many possible directions and topics we could pursue within this vast space. Reviewing previous AD-themed editions, I saw perspectives on advances in technology with increasing application specificity, discussions on when and in whom, proper technique, and probing of the ever-growing list of unanswered AD questions.
Introduction - Endovascular Today

Nov 1, 2024 | evtoday.com | Mitchell Silver

This focused supplement to Endovascular Today comes on the heels of the recent FDA approval of the Neuroguard IEP® System, a 3-in-1 carotid stent + dilation balloon + Integrated Embolic Protection (IEP) system (Contego Medical). This FDA approval is supported by unprecedented safety outcomes from the PERFORMANCE I and II trials, which will be reviewed herein.
PTAB With the DETOUR™ System for the Management of Long SFA Disease

Aug 22, 2024 | evtoday.com | Prakash Krishnan |With Ajit Rao

Ajit Rao, MD, RPVI, FACS Director of Vascular Surgery Research Director of Vascular Surgery Simulation Center Associate Professor of Surgery and Radiology Icahn School of Medicine at Mount Sinai New York, New York Disclosures: None. Prakash Krishnan, MD, FACC, FSCAI Director of Endovascular Interventions Co-Director of Complex Coronary & Vascular Cases Professor of Cardiology and Radiology Icahn School of Medicine at Mount Sinai New York, New York Disclosures: None.
Spinal Drains: When, How, in and by Whom, and Optimal Follow-Up

Aug 22, 2024 | evtoday.com | Kristine Orion

Spinal cord ischemia (SCI) is a known risk after both open and endovascular approaches to aortic repair and is the most feared complication after aortic surgery. Many of my patients have a harder time coping with the thought of being bound to a wheelchair for the rest of their lives than accepting death. It is not something to be taken lightly in the preoperative setting.
Recapping Influential Superficial Venous Trials

Jul 25, 2024 | evtoday.com | Manj S. Gohel

Modern venous practice is a complex and dynamic environment involving many professionals and multiple treatment options. It is important to appreciate that high-quality, prospective clinical trials underpin modern clinical practice, including what we do daily. Clinical evidence provides the foundation from which we can be the patient’s advocate and offer reliable clinical advice and guidance.
The Future of Carotid Artery Revascularization: Putting It All Together

Jun 19, 2024 | evtoday.com | Kenneth Rosenfield

Perspectives on the effects of microembolization, protection strategies, recent clinical trial findings, and why carotid stenting should be part of a vascular specialist’s armamentarium.
Case Report: Revascularization of Femoropopliteal and Tibiopedal Total Occlusions Facilitated by Use of the Sublime™ Microcatheter

May 23, 2024 | evtoday.com | Craig Walker

A man in his mid 70s with a history of peripheral artery disease (PAD), tobacco use (former), hypertension, chronic lung disease, and dyslipidemia presented to the clinic with severe PAD with true ischemic rest pain in the right lower extremity (Rutherford class 4) and prior femoropopliteal bypass surgery.
Bioresorbable Scaffolds: Do Recent Study Results Support Revival for Use in the BTK Arteries?

May 22, 2024 | evtoday.com | Marianne Brodmann

Endovascular treatment options for peripheral artery disease have improved tremendously over the last few years. A milestone achievement was the development of drug-coated balloons (DCBs) and drug-eluting stents, and now, with the availability of vessel preparation tools, the current first-line strategy is use of DCBs after optimal vessel preparation and the shortest possible scaffold in cases of mechanical issues (ie, the so-called “leave as little metal behind as possible” strategy).